Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Sarcopenia Is a Clinically Relevant and Independent Predictor of Health Outcomes after Chimeric Antigen Receptor T-Cell Therapy for Lymphoma

Alex Iukuridze, Jennifer Berano Teh, Justin Ramos, Teresa Cabrera Vera, Kyuwan Lee, Rusha Bhandari, Andrew S. Artz, Elizabeth Budde, Alex F. Herrera, Leslie L. Popplewell, Geoffrey Shouse, Tanya Siddiqi, Stephen J Forman, Lennie Wong, Saro H. Armenian

Blood (2021) 138 (Supplement 1): 2502.

https://doi.org/10.1182/blood-2021-149784

Published: 2021

Journal Articles

Social Vulnerability Is a Clinically Important Predictor of Outcomes after Allogeneic Hematopoietic Cell Transplantation

Rusha Bhandari, Jennifer Berano Teh, Ryotaro Nakamura, Andrew S. Artz, Stephen J Forman, Lennie Wong, Saro H. Armenian

Blood (2021) 138 (Supplement 1): 842.

https://doi.org/10.1182/blood-2021-146633

Published: 2021

Journal Articles

Incidence and Risk Factors of De Novo Skin Cancer in a Contemporary Cohort of Hematopoietic Cell Transplantation Survivors

Jennifer Berano Teh, Farah Abdulla, MD, Kelly Peng, Liezl Atencio, Alicia Gonzales, Meagan Echevarria, Alex Iukuridze, Alan Geller, Heeyoung Kim, Lennie Wong, PhD, Stephen J Forman, MD, Ryotaro Nakamura, MD, Badri Modi, MD, Saro H. Armenian, DO, MPH

Blood (2019) 134 (Supplement_1): 2011.

https://doi.org/10.1182/blood-2019-124993

Published: 2019

Journal Articles

Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling

Benjamin Djulbegovic, MD, Jennifer Berano Teh, Lennie Wong, PhD, Iztok Hozo, PhD, Saro H. Armenian, DO, MPH

Blood (2019) 134 (Supplement_1): 5799.

https://doi.org/10.1182/blood-2019-130764

Published: 2019

Journal Articles

Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation

Alex Iukuridze, Meisi Xiao, MPH, Lee Brandyn, Jennifer Berano Teh, Kristen Mascarenhas, Sandra Xu, Nicholas Rosen, Jeannine S McCune, PharmD, Jasmine M. Zain, MD, Robert W. Chen, MD, Leslie Popplewell, MD, Jessica Scott, PhD, Thomas Slavin, MD, Lee Jones, PhD, Stephen J Forman, Ryotaro Nakamura, MD, F. Lennie Wong, PhD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 620.

https://doi.org/10.1182/blood-2018-99-113689

Published: 2018

Journal Articles

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

F. Lennie Wong, PhD, Meisi Xiao, MPH, Jennifer Berano Teh, Liezl Atencio, Alicia Gonzales, Amy Hinton, David Iukuridze, Stephen J Forman, Ryotaro Nakamura, MD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 368.

https://doi.org/10.1182/blood-2018-99-112646

Published: 2018

Journal Articles

Sarcopenia Is a Clinically Relevant and Independent Predictor of Adverse Outcomes after Allogeneic Hematopoietic Cell Transplantation

Saro H. Armenian, DO,MPH, Dongyun Yang, PhD, Jennifer Berano Teh, Brandyn Lee, Howard Chang, Mascarenhas Kristen, Lee Sean, Iukuridze Aleksi, Jack Ji Xie, Jessica Scott, Lee Jones, F. Lennie Wong, Stephen J. Forman, MD, Ryotaro Nakamura

Blood (2017) 130 (Supplement 1): 1991.

https://doi.org/10.1182/blood.V130.Suppl_1.1991.1991

Published: 2017

Journal Articles

Impact of Self-Reported Pre-Transplant Quality of Life (QOL) on Long-Term Survival after Allogeneic or Autologous Hematopoietic Cell Transplantation (HCT)

F. Lennie Wong, PhD, Jennifer Berano-Teh, Liton F. Francisco, BS, Aida Siyahian, Liezl Atencio, Alicia Gonzales, Saro Armenian, DO, MPH, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2016) 128 (22): 3598.

https://doi.org/10.1182/blood.V128.22.3598.3598

Published: 2016

Journal Articles

Incidence and Predictors of Late-Occurring Central Nervous System Complications in Allogeneic Hematopoietic Cell Transplant Survivors

Aida Siyahian, Heeyoung Kim, MS, Jennifer Berano Teh, Howard Chang, Liezl Atencio, Alicia Gonzales, F. Lennie Wong, PhD, Ryotaro Nakamura, MD, Canlan Sun, PhD, Saro Armenian, DO, MPH

Blood (2016) 128 (22): 5799.

https://doi.org/10.1182/blood.V128.22.5799.5799

Published: 2016

Journal Articles

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD MS, Can-Lan Sun, PhD, Kirsten K. Ness, PhD, Jennifer Berano Teh, MD, Jessica Wu, Liton F. Francisco, BS, Saro Armenian, DO, MPH, Amy Schad, MPH, CCRP, Golnaz Namdar, MPH, Alysia Bosworth, Linus Kuo, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2015) 126 (23): 739.

https://doi.org/10.1182/blood.V126.23.739.739

Published: 2015

Journal Articles

Do Changes in Transplant Practice Influence Risk of Therapy-Related Myelodysplasia/ Acute Myeloid Leukemia after Autologous Hematopoietic Cell Transplantation (aHCT) for Non-Hodgkin Lymphoma (NHL)?

Can-Lan Sun, Jennifer Berano-Teh, Patrick Halliday, Lindsey Hageman, Maya Ramamurthy, Saro Armenian, Alicia Gonzales, Liezl Atencio, Liton Francisco, F. Lennie Wong, Auayporn Nademanee, MD, Robert W Chen, MD, Margaret O'Donnell, Joseph Rosenthal, Leslie L. Popplewell, MD, Shirong Wang, Stephen J. Forman, Ravi Bhatia, Smita Bhatia, PhD

Blood (2014) 124 (21): 430.

https://doi.org/10.1182/blood.V124.21.430.430

Published: 2014

Journal Articles

Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Saro H. Armenian, Can-Lan Sun, Toana Kawashima, Mukta Arora, Wendy Leisenring, Charles A. Sklar, K. Scott Baker, Liton Francisco, Jennifer Berano Teh, George Mills, F. Lennie Wong, Joseph Rosenthal, Lisa R. Diller, Melissa M. Hudson, Kevin C. Oeffinger, Stephen J. Forman, Leslie L. Robison, Smita Bhatia

Blood (2011) 118 (5): 1413–1420.

https://doi.org/10.1182/blood-2011-01-331835

Published: 2011

Includes: Supplemental data

Journal Articles

Cause-Specific Conditional Survival In 2603 Consecutive Patients Undergoing Autologous Hematopoietic Cell Transplantation (aHCT) Over a 20-Year Period

Ari M. Vander Walde, M.D., M.P.H., Can-Lan Sun, Ph.D., Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Neal Kogut, M.D., Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia

Blood (2010) 116 (21): 933.

https://doi.org/10.1182/blood.V116.21.933.933

Published: 2010

Journal Articles

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Lester A. Laddaran, B.A., Can-Lan Sun, Ph.D., Ari M. VanderWalde, MD, MPH, Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Chatchada Karanes, MD, Neil Martin Kogut, MD, Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Margaret O'Donnell, M.D., F.R.C.P.C., Pablo Parker, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia

Blood (2010) 116 (21): 902.

https://doi.org/10.1182/blood.V116.21.902.902

Published: 2010

Journal Articles

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Saro Armenian, DO, MPH, Can-Lan Sun, Ph.D., Toana Kawashima, MS, Mukta Arora, MD, Wendy Leisenring, ScD, Charles A. Sklar, MD, K. Scott Baker, MD, MS, Liton Francisco, Jennifer Berano Teh, MD, George Mills, III, F. Lennie Wong, PhD, Joseph Rosenthal, MD, Lisa Diller, MD, Melissa M. Hudson, MD, Kevin C. Oeffinger, MD, Leslie L. Robison, PhD, Smita Bhatia, MD, MPH

Blood (2010) 116 (21): 217.

https://doi.org/10.1182/blood.V116.21.217.217

Published: 2010

Journal Articles

Late Cardiovascular Events in Survivors of Hematopoietic Cell Transplantation (HCT).

Saro Armenian, DO, MPH, Can-Lan Sun, PhD, George Mills, III, BS, Jennifer Berano Teh, MD, Liton Francisco, BS, Lennie Wong, PhD, Stephen J Forman, MD, Smita Bhatia, MD, MPH

Blood (2009) 114 (22): 2252.

https://doi.org/10.1182/blood.V114.22.2252.2252

Published: 2009

NARROW

Sarcopenia Is a Clinically Relevant and Independent Predictor of Health Outcomes after Chimeric Antigen Receptor T-Cell Therapy for Lymphoma

Social Vulnerability Is a Clinically Important Predictor of Outcomes after Allogeneic Hematopoietic Cell Transplantation

Incidence and Risk Factors of De Novo Skin Cancer in a Contemporary Cohort of Hematopoietic Cell Transplantation Survivors

Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling

Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

Sarcopenia Is a Clinically Relevant and Independent Predictor of Adverse Outcomes after Allogeneic Hematopoietic Cell Transplantation

Impact of Self-Reported Pre-Transplant Quality of Life (QOL) on Long-Term Survival after Allogeneic or Autologous Hematopoietic Cell Transplantation (HCT)

Incidence and Predictors of Late-Occurring Central Nervous System Complications in Allogeneic Hematopoietic Cell Transplant Survivors

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Do Changes in Transplant Practice Influence Risk of Therapy-Related Myelodysplasia/ Acute Myeloid Leukemia after Autologous Hematopoietic Cell Transplantation (aHCT) for Non-Hodgkin Lymphoma (NHL)?

Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Cause-Specific Conditional Survival In 2603 Consecutive Patients Undergoing Autologous Hematopoietic Cell Transplantation (aHCT) Over a 20-Year Period

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Late Cardiovascular Events in Survivors of Hematopoietic Cell Transplantation (HCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only